Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1519563

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1519563

LAMEA Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 136 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Cat Vaccine Market would witness market growth of 11.7% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Cat Vaccine Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $54 million by 2031. The Argentina market is capturing a CAGR of 12.6% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 10.9% during (2024 - 2031).

The development of recombinant DNA technology has enabled the production of vaccines that can target specific pathogens with greater precision. This method reduces the risk of adverse reactions and enhances the immune response in cats. As a result, newer vaccines can offer longer-lasting protection against diseases such as feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), and rabies, contributing to cats' overall health and longevity.

Despite the positive trends, the market also faces several challenges. One of the most significant barriers is the high cost of vaccines, which can deter pet owners, especially those with multiple cats or limited financial resources. Even with the availability of pet insurance, the upfront costs associated with comprehensive vaccination schedules can be prohibitive for some. This financial burden can lower vaccination rates, leaving cats vulnerable to preventable diseases.

The South African Veterinary Association (SAVA) has actively promoted the importance of regular vaccinations through public health initiatives and educational campaigns. The Department of Agriculture, Forestry, and Fisheries (DAFF) supports these efforts by ensuring that veterinary services are accessible and affordable. The demand for cat vaccines has been driven by enhanced public awareness and the increasing disposable income of pet owners, who are more inclined to invest in preventive healthcare for their animals. Thus, the LAMEA cat vaccine market has growth potential fueled by rising pet ownership and increasing awareness of animal welfare.

Based on Component, the market is segmented into Combined Vaccines, and Mono Vaccines. Based on Route of Administration, the market is segmented into Injectables, Intranasal, and Oral. Based on Duration of Immunity, the market is segmented into 1 Year, 3 Year, and Others. Based on Disease Type, the market is segmented into Feline Respiratory Diseases, Feline Rabies, Feline Panleukopenia (Feline Distemper), Feline Leukemia, and Others. Based on Type, the market is segmented into Modified/Attenuated Live, Inactivated (Killed), and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Zoetis, Inc.
  • Elanco Animal Health, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
  • Virbac
  • Heska Corporation (Antech Diagnostics, Inc)
  • Ceva Sante Animale
  • Bioveta, a.s.

LAMEA Cat Vaccine Market Report Segmentation

By Component

  • Combined Vaccines
  • Mono Vaccines

By Route of Administration

  • Injectables
  • Intranasal
  • Oral

By Duration of Immunity

  • 1 Year
  • 3 Year
  • Others

By Disease Type

  • Feline Respiratory Diseases
  • Feline Rabies
  • Feline Panleukopenia (Feline Distemper)
  • Feline Leukemia
  • Others

By Type

  • Modified/Attenuated Live
  • Inactivated (Killed)
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Cat Vaccine Market, by Component
    • 1.4.2 LAMEA Cat Vaccine Market, by Route of Administration
    • 1.4.3 LAMEA Cat Vaccine Market, by Duration of Immunity
    • 1.4.4 LAMEA Cat Vaccine Market, by Disease Type
    • 1.4.5 LAMEA Cat Vaccine Market, by Type
    • 1.4.6 LAMEA Cat Vaccine Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Cat Vaccine Market

Chapter 5. LAMEA Cat Vaccine Market by Component

  • 5.1 LAMEA Combined Vaccines Market by Country
  • 5.2 LAMEA Mono Vaccines Market by Country

Chapter 6. LAMEA Cat Vaccine Market by Route of Administration

  • 6.1 LAMEA Injectables Market by Country
  • 6.2 LAMEA Intranasal Market by Country
  • 6.3 LAMEA Oral Market by Country

Chapter 7. LAMEA Cat Vaccine Market by Duration of Immunity

  • 7.1 LAMEA 1 Year Market by Country
  • 7.2 LAMEA 3 Year Market by Country
  • 7.3 LAMEA Others Market by Country

Chapter 8. LAMEA Cat Vaccine Market by Disease Type

  • 8.1 LAMEA Feline Respiratory Diseases Market by Country
  • 8.2 LAMEA Feline Rabies Market by Country
  • 8.3 LAMEA Feline Panleukopenia (Feline Distemper) Market by Country
  • 8.4 LAMEA Feline Leukemia Market by Country
  • 8.5 LAMEA Others Market by Country

Chapter 9. LAMEA Cat Vaccine Market by Type

  • 9.1 LAMEA Modified/Attenuated Live Market by Country
  • 9.2 LAMEA Inactivated (Killed) Market by Country
  • 9.3 LAMEA Others Market by Country

Chapter 10. LAMEA Cat Vaccine Market by Country

  • 10.1 Brazil Cat Vaccine Market
    • 10.1.1 Brazil Cat Vaccine Market by Component
    • 10.1.2 Brazil Cat Vaccine Market by Route of Administration
    • 10.1.3 Brazil Cat Vaccine Market by Duration of Immunity
    • 10.1.4 Brazil Cat Vaccine Market by Disease Type
    • 10.1.5 Brazil Cat Vaccine Market by Type
  • 10.2 Argentina Cat Vaccine Market
    • 10.2.1 Argentina Cat Vaccine Market by Component
    • 10.2.2 Argentina Cat Vaccine Market by Route of Administration
    • 10.2.3 Argentina Cat Vaccine Market by Duration of Immunity
    • 10.2.4 Argentina Cat Vaccine Market by Disease Type
    • 10.2.5 Argentina Cat Vaccine Market by Type
  • 10.3 UAE Cat Vaccine Market
    • 10.3.1 UAE Cat Vaccine Market by Component
    • 10.3.2 UAE Cat Vaccine Market by Route of Administration
    • 10.3.3 UAE Cat Vaccine Market by Duration of Immunity
    • 10.3.4 UAE Cat Vaccine Market by Disease Type
    • 10.3.5 UAE Cat Vaccine Market by Type
  • 10.4 Saudi Arabia Cat Vaccine Market
    • 10.4.1 Saudi Arabia Cat Vaccine Market by Component
    • 10.4.2 Saudi Arabia Cat Vaccine Market by Route of Administration
    • 10.4.3 Saudi Arabia Cat Vaccine Market by Duration of Immunity
    • 10.4.4 Saudi Arabia Cat Vaccine Market by Disease Type
    • 10.4.5 Saudi Arabia Cat Vaccine Market by Type
  • 10.5 South Africa Cat Vaccine Market
    • 10.5.1 South Africa Cat Vaccine Market by Component
    • 10.5.2 South Africa Cat Vaccine Market by Route of Administration
    • 10.5.3 South Africa Cat Vaccine Market by Duration of Immunity
    • 10.5.4 South Africa Cat Vaccine Market by Disease Type
    • 10.5.5 South Africa Cat Vaccine Market by Type
  • 10.6 Nigeria Cat Vaccine Market
    • 10.6.1 Nigeria Cat Vaccine Market by Component
    • 10.6.2 Nigeria Cat Vaccine Market by Route of Administration
    • 10.6.3 Nigeria Cat Vaccine Market by Duration of Immunity
    • 10.6.4 Nigeria Cat Vaccine Market by Disease Type
    • 10.6.5 Nigeria Cat Vaccine Market by Type
  • 10.7 Rest of LAMEA Cat Vaccine Market
    • 10.7.1 Rest of LAMEA Cat Vaccine Market by Component
    • 10.7.2 Rest of LAMEA Cat Vaccine Market by Route of Administration
    • 10.7.3 Rest of LAMEA Cat Vaccine Market by Duration of Immunity
    • 10.7.4 Rest of LAMEA Cat Vaccine Market by Disease Type
    • 10.7.5 Rest of LAMEA Cat Vaccine Market by Type

Chapter 11. Company Profiles

  • 11.1 Zoetis, Inc.
    • 11.1.1 Company Overview
    • 11.1.2 Financial Analysis
    • 11.1.3 Regional Analysis
    • 11.1.4 Research & Development Expenses
    • 11.1.5 Recent strategies and developments:
      • 11.1.5.1 Partnerships, Collaborations, and Agreements:
      • 11.1.5.2 Product Launches and Product Expansions:
      • 11.1.5.3 Acquisition and Mergers:
    • 11.1.6 SWOT Analysis
  • 11.2 Elanco Animal Health, Inc.
    • 11.2.1 Company Overview
    • 11.2.2 Financial Analysis
    • 11.2.3 Regional Analysis
    • 11.2.4 Research & Development Expenses
    • 11.2.5 SWOT Analysis
  • 11.3 Merck & Co., Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Financial Analysis
    • 11.3.3 Segmental and Regional Analysis
    • 11.3.4 Research & Development Expenses
    • 11.3.5 SWOT Analysis
  • 11.4 Boehringer Ingelheim International GmbH
    • 11.4.1 Company Overview
    • 11.4.2 Financial Analysis
    • 11.4.3 Regional & Segmental Analysis
    • 11.4.4 Research & Development Expenses
    • 11.4.5 Recent strategies and developments:
      • 11.4.5.1 Trials and Approvals:
    • 11.4.6 SWOT Analysis
  • 11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
    • 11.5.1 Company Overview
    • 11.5.2 SWOT Analysis
  • 11.6 Virbac
    • 11.6.1 Company Overview
    • 11.6.2 Financial Analysis
    • 11.6.3 Regional Analysis
    • 11.6.4 Recent strategies and developments:
      • 11.6.4.1 Acquisition and Mergers:
    • 11.6.5 SWOT Analysis
  • 11.7 Heska Corporation (Antech Diagnostics, Inc)
    • 11.7.1 Company Overview
    • 11.7.2 SWOT Analysis
  • 11.8 Ceva Sante Animale
    • 11.8.1 Company Overview
    • 11.8.2 SWOT Analysis
  • 11.9 Bioveta, a.s.
    • 11.9.1 Company Overview

LIST OF TABLES

  • TABLE 1 LAMEA Cat Vaccine Market, 2020 - 2023, USD Million
  • TABLE 2 LAMEA Cat Vaccine Market, 2024 - 2031, USD Million
  • TABLE 3 LAMEA Cat Vaccine Market by Component, 2020 - 2023, USD Million
  • TABLE 4 LAMEA Cat Vaccine Market by Component, 2024 - 2031, USD Million
  • TABLE 5 LAMEA Combined Vaccines Market by Country, 2020 - 2023, USD Million
  • TABLE 6 LAMEA Combined Vaccines Market by Country, 2024 - 2031, USD Million
  • TABLE 7 LAMEA Mono Vaccines Market by Country, 2020 - 2023, USD Million
  • TABLE 8 LAMEA Mono Vaccines Market by Country, 2024 - 2031, USD Million
  • TABLE 9 LAMEA Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 10 LAMEA Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 11 LAMEA Injectables Market by Country, 2020 - 2023, USD Million
  • TABLE 12 LAMEA Injectables Market by Country, 2024 - 2031, USD Million
  • TABLE 13 LAMEA Intranasal Market by Country, 2020 - 2023, USD Million
  • TABLE 14 LAMEA Intranasal Market by Country, 2024 - 2031, USD Million
  • TABLE 15 LAMEA Oral Market by Country, 2020 - 2023, USD Million
  • TABLE 16 LAMEA Oral Market by Country, 2024 - 2031, USD Million
  • TABLE 17 LAMEA Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
  • TABLE 18 LAMEA Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
  • TABLE 19 LAMEA 1 Year Market by Country, 2020 - 2023, USD Million
  • TABLE 20 LAMEA 1 Year Market by Country, 2024 - 2031, USD Million
  • TABLE 21 LAMEA 3 Year Market by Country, 2020 - 2023, USD Million
  • TABLE 22 LAMEA 3 Year Market by Country, 2024 - 2031, USD Million
  • TABLE 23 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 24 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 25 LAMEA Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
  • TABLE 26 LAMEA Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
  • TABLE 27 LAMEA Feline Respiratory Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 28 LAMEA Feline Respiratory Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 29 LAMEA Feline Rabies Market by Country, 2020 - 2023, USD Million
  • TABLE 30 LAMEA Feline Rabies Market by Country, 2024 - 2031, USD Million
  • TABLE 31 LAMEA Feline Panleukopenia (Feline Distemper) Market by Country, 2020 - 2023, USD Million
  • TABLE 32 LAMEA Feline Panleukopenia (Feline Distemper) Market by Country, 2024 - 2031, USD Million
  • TABLE 33 LAMEA Feline Leukemia Market by Country, 2020 - 2023, USD Million
  • TABLE 34 LAMEA Feline Leukemia Market by Country, 2024 - 2031, USD Million
  • TABLE 35 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 36 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 37 LAMEA Cat Vaccine Market by Type, 2020 - 2023, USD Million
  • TABLE 38 LAMEA Cat Vaccine Market by Type, 2024 - 2031, USD Million
  • TABLE 39 LAMEA Modified/Attenuated Live Market by Country, 2020 - 2023, USD Million
  • TABLE 40 LAMEA Modified/Attenuated Live Market by Country, 2024 - 2031, USD Million
  • TABLE 41 LAMEA Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
  • TABLE 42 LAMEA Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
  • TABLE 43 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 44 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 45 LAMEA Cat Vaccine Market by Country, 2020 - 2023, USD Million
  • TABLE 46 LAMEA Cat Vaccine Market by Country, 2024 - 2031, USD Million
  • TABLE 47 Brazil Cat Vaccine Market, 2020 - 2023, USD Million
  • TABLE 48 Brazil Cat Vaccine Market, 2024 - 2031, USD Million
  • TABLE 49 Brazil Cat Vaccine Market by Component, 2020 - 2023, USD Million
  • TABLE 50 Brazil Cat Vaccine Market by Component, 2024 - 2031, USD Million
  • TABLE 51 Brazil Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 52 Brazil Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 53 Brazil Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
  • TABLE 54 Brazil Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
  • TABLE 55 Brazil Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
  • TABLE 56 Brazil Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
  • TABLE 57 Brazil Cat Vaccine Market by Type, 2020 - 2023, USD Million
  • TABLE 58 Brazil Cat Vaccine Market by Type, 2024 - 2031, USD Million
  • TABLE 59 Argentina Cat Vaccine Market, 2020 - 2023, USD Million
  • TABLE 60 Argentina Cat Vaccine Market, 2024 - 2031, USD Million
  • TABLE 61 Argentina Cat Vaccine Market by Component, 2020 - 2023, USD Million
  • TABLE 62 Argentina Cat Vaccine Market by Component, 2024 - 2031, USD Million
  • TABLE 63 Argentina Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 64 Argentina Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 65 Argentina Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
  • TABLE 66 Argentina Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
  • TABLE 67 Argentina Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
  • TABLE 68 Argentina Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
  • TABLE 69 Argentina Cat Vaccine Market by Type, 2020 - 2023, USD Million
  • TABLE 70 Argentina Cat Vaccine Market by Type, 2024 - 2031, USD Million
  • TABLE 71 UAE Cat Vaccine Market, 2020 - 2023, USD Million
  • TABLE 72 UAE Cat Vaccine Market, 2024 - 2031, USD Million
  • TABLE 73 UAE Cat Vaccine Market by Component, 2020 - 2023, USD Million
  • TABLE 74 UAE Cat Vaccine Market by Component, 2024 - 2031, USD Million
  • TABLE 75 UAE Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 76 UAE Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 77 UAE Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
  • TABLE 78 UAE Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
  • TABLE 79 UAE Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
  • TABLE 80 UAE Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
  • TABLE 81 UAE Cat Vaccine Market by Type, 2020 - 2023, USD Million
  • TABLE 82 UAE Cat Vaccine Market by Type, 2024 - 2031, USD Million
  • TABLE 83 Saudi Arabia Cat Vaccine Market, 2020 - 2023, USD Million
  • TABLE 84 Saudi Arabia Cat Vaccine Market, 2024 - 2031, USD Million
  • TABLE 85 Saudi Arabia Cat Vaccine Market by Component, 2020 - 2023, USD Million
  • TABLE 86 Saudi Arabia Cat Vaccine Market by Component, 2024 - 2031, USD Million
  • TABLE 87 Saudi Arabia Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 88 Saudi Arabia Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 89 Saudi Arabia Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
  • TABLE 90 Saudi Arabia Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
  • TABLE 91 Saudi Arabia Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
  • TABLE 92 Saudi Arabia Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
  • TABLE 93 Saudi Arabia Cat Vaccine Market by Type, 2020 - 2023, USD Million
  • TABLE 94 Saudi Arabia Cat Vaccine Market by Type, 2024 - 2031, USD Million
  • TABLE 95 South Africa Cat Vaccine Market, 2020 - 2023, USD Million
  • TABLE 96 South Africa Cat Vaccine Market, 2024 - 2031, USD Million
  • TABLE 97 South Africa Cat Vaccine Market by Component, 2020 - 2023, USD Million
  • TABLE 98 South Africa Cat Vaccine Market by Component, 2024 - 2031, USD Million
  • TABLE 99 South Africa Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 100 South Africa Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 101 South Africa Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
  • TABLE 102 South Africa Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
  • TABLE 103 South Africa Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
  • TABLE 104 South Africa Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
  • TABLE 105 South Africa Cat Vaccine Market by Type, 2020 - 2023, USD Million
  • TABLE 106 South Africa Cat Vaccine Market by Type, 2024 - 2031, USD Million
  • TABLE 107 Nigeria Cat Vaccine Market, 2020 - 2023, USD Million
  • TABLE 108 Nigeria Cat Vaccine Market, 2024 - 2031, USD Million
  • TABLE 109 Nigeria Cat Vaccine Market by Component, 2020 - 2023, USD Million
  • TABLE 110 Nigeria Cat Vaccine Market by Component, 2024 - 2031, USD Million
  • TABLE 111 Nigeria Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 112 Nigeria Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 113 Nigeria Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
  • TABLE 114 Nigeria Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
  • TABLE 115 Nigeria Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
  • TABLE 116 Nigeria Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
  • TABLE 117 Nigeria Cat Vaccine Market by Type, 2020 - 2023, USD Million
  • TABLE 118 Nigeria Cat Vaccine Market by Type, 2024 - 2031, USD Million
  • TABLE 119 Rest of LAMEA Cat Vaccine Market, 2020 - 2023, USD Million
  • TABLE 120 Rest of LAMEA Cat Vaccine Market, 2024 - 2031, USD Million
  • TABLE 121 Rest of LAMEA Cat Vaccine Market by Component, 2020 - 2023, USD Million
  • TABLE 122 Rest of LAMEA Cat Vaccine Market by Component, 2024 - 2031, USD Million
  • TABLE 123 Rest of LAMEA Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 124 Rest of LAMEA Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 125 Rest of LAMEA Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
  • TABLE 126 Rest of LAMEA Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
  • TABLE 127 Rest of LAMEA Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
  • TABLE 128 Rest of LAMEA Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
  • TABLE 129 Rest of LAMEA Cat Vaccine Market by Type, 2020 - 2023, USD Million
  • TABLE 130 Rest of LAMEA Cat Vaccine Market by Type, 2024 - 2031, USD Million
  • TABLE 131 Key Information - Zoetis, Inc.
  • TABLE 132 Key information - Elanco Animal Health, Inc.
  • TABLE 133 Key Information - Merck & Co., Inc.
  • TABLE 134 Key Information - Boehringer Ingelheim International GmbH
  • TABLE 135 Key Information - Covetrus, Inc.
  • TABLE 136 Key Information - Virbac
  • TABLE 137 Key Information - Heska Corporation
  • TABLE 138 Key Information - Ceva SantE Animale
  • TABLE 139 Key Information - Bioveta, a.s.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!